PBE Among Technology ETFs
End-of-day Nov 16, 2026 · 51 Technology ETFs by 1Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −2.1% | −5.0% | −0.3% | +0.6% | +17.9% | +25.4% | +83.0% | +32.2% | +436.2% |
| Peer average | −2.9% | −3.9% | −7.3% | −10.9% | +3.1% | +4.6% | +69.6% | +21.7% | — |
| S&P 500 · VOO | −1.9% | −1.7% | −3.0% | −3.3% | +9.4% | +11.3% | +77.3% | +69.2% | — |
$58 of every $1,000 in PBE is Biogen
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | BIIBBiogen | Healthcare | 5.78% | $578.41 | 99K | $25.1M |
| 2 | REGNRegeneron Pharmaceuticals | Healthcare | 5.78% | $577.53 | 26K | $25.1M |
| 3 | GILDGilead Sciences | Healthcare | 5.69% | $569.30 | 147K | $24.8M |
| 4 | RPRXRoyalty Pharma | Healthcare | 5.63% | $562.66 | 353K | $24.5M |
| 5 | AMGNAmgen | Healthcare | 5.31% | $530.62 | 50K | $23.1M |
| 6 | VRTXVertex Pharmaceuticals | Healthcare | 4.91% | $490.87 | 40K | $21.3M |
| 7 | NTRANatera | Healthcare | 4.78% | $477.55 | 65K | $20.8M |
| 8 | ILMNIllumina | Healthcare | 4.64% | $463.61 | 97K | $20.2M |
| 9 | MRNAModerna | Healthcare | 3.87% | $386.53 | 75K | $16.8M |
| 10 | VCELVericel | Healthcare | 3.62% | $362.23 | 276K | $15.7M |
| 11 | EXELExelixis | Healthcare | 3.34% | $334.36 | 211K | $14.5M |
| 12 | TGTXTG Therapeutics | Healthcare | 3.20% | $319.93 | 216K | $13.9M |
| 13 | QGENQiagen | Healthcare | 3.14% | $314.14 | 274K | $13.7M |
| 14 | UTHRUnited Therapeutics | Healthcare | 3.13% | $313.37 | 23K | $13.6M |
| 15 | NBIXNeurocrine Biosciences | Healthcare | 3.00% | $299.98 | 78K | $13.0M |
of the $354B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | BIIB | Biogen | 5.78% |
| 2 | REGN | Regeneron Pharmaceuticals | 5.78% |
| 3 | GILD | Gilead Sciences | 5.69% |
| 4 | RPRX | Royalty Pharma | 5.63% |
| 5 | AMGN | Amgen | 5.31% |
| 6 | VRTX | Vertex Pharmaceuticals | 4.91% |
| 7 | NTRA | Natera | 4.78% |
| 8 | ILMN | Illumina | 4.64% |
| 9 | MRNA | Moderna | 3.87% |
| 10 | VCEL | Vericel | 3.62% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.0187 |
| Jun 22, 2026 | Jun 26, 2026 | $0.81 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0824 |
| Dec 22, 2025 | Dec 26, 2025 | $0.42 |
| Sep 22, 2025 | Sep 26, 2025 | $0.23 |
| Jun 23, 2025 | Jun 27, 2025 | $0.13 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0341 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0082 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0242 |
| Jun 20, 2023 | Jun 23, 2023 | $0.0141 |
| Mar 23, 2020 | Mar 31, 2020 | $0.0290 |
| Sep 24, 2018 | Sep 28, 2018 | $0.0021 |